表紙
市場調查報告書

軟組織再生材料 - 醫療設備的開發平台評估

Tissue Regenerative Materials - Medical Devices Pipeline Assessment, 2019

出版商 GlobalData 商品編碼 920905
出版日期 內容資訊 英文 62 Pages
訂單完成後即時交付
價格
Back to Top
軟組織再生材料 - 醫療設備的開發平台評估 Tissue Regenerative Materials - Medical Devices Pipeline Assessment, 2019
出版日期: 2019年12月24日內容資訊: 英文 62 Pages
簡介

本報告提供目前開發中的軟組織再生材料的開發中產品資訊調查分析,提供主要產品·計劃,主要企業,臨床實驗資訊,最近的趨勢等相關的系統性資訊。

第1章 目錄

第2章 簡介

  • 軟組織再生材料概要

第3章 開發中的產品

  • 軟組織再生材料 - 開發中產品:各開發階段
  • 軟組織再生材料 - 開發中產品:各地區
  • 軟組織再生材料 - 開發中產品:各法規途徑
  • 軟組織再生材料 - 開發中產品:各核准時期 (預定)

第4章 軟組織再生材料:正在開發的開發中產品 (各企業)

  • 軟組織再生材料企業 - 開發中產品:各開發階段
  • 軟組織再生材料 - 開發中產品:各開發階段

第5章 軟組織再生材料企業與產品概要

  • Biora AB
  • Collagen Matrix Inc
  • Colorado Therapeutics, LLC
  • credentis AG
  • Gene Techno Science Co Ltd

第6章 軟組織再生材料:最近的趨勢

第7章 附錄

目錄
Product Code: GDME0900EPD

GlobalData's Medical Devices sector report, "Tissue Regenerative Materials - Medical Devices Pipeline Assessment, 2019" provides an overview of Tissue Regenerative Materials currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Tissue Regenerative Materials pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Tissue Regenerative Materials under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Tissue Regenerative Materials and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Tissue Regenerative Materials under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 4
  • 1.2 List of Figures 5

2 Introduction 6

  • 2.1 Tissue Regenerative Materials Overview 6

3 Products under Development 7

  • 3.1 Tissue Regenerative Materials - Pipeline Products by Stage of Development 7
  • 3.2 Tissue Regenerative Materials - Pipeline Products by Territory 8
  • 3.3 Tissue Regenerative Materials - Pipeline Products by Regulatory Path 9
  • 3.4 Tissue Regenerative Materials - Pipeline Products by Estimated Approval Date 10

4 Tissue Regenerative Materials - Pipeline Products under Development by Companies 11

  • 4.1 Tissue Regenerative Materials Companies - Pipeline Products by Stage of Development 11
  • 4.2 Tissue Regenerative Materials - Pipeline Products by Stage of Development 12

5 Tissue Regenerative Materials Companies and Product Overview 13

  • 5.1 Biora AB Company Overview 13
    • 5.1.1 Biora AB Pipeline Products & Ongoing Clinical Trials Overview 13
  • 5.2 Collagen Matrix Inc Company Overview 14
    • 5.2.1 Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview 14
  • 5.3 Colorado Therapeutics, LLC Company Overview 16
    • 5.3.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.4 credentis AG Company Overview 17
    • 5.4.1 credentis AG Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.5 Gene Techno Science Co Ltd Company Overview 18
    • 5.5.1 Gene Techno Science Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 18

6 Tissue Regenerative Materials- Recent Developments 31

  • 6.1 Oct 22, 2019: CollPlant CEO Yehiel Tal appointed to serve on international society for Biofabrication's Industry Relations Committee 31
  • 6.2 Sep 26, 2019: CollPlant reports second quarter 2019 financial results and provides business update 31
  • 6.3 Aug 29, 2019: Straumann Group announces two appointments to its Executive Management team 33
  • 6.4 Aug 14, 2019: Straumann Group: Strong momentum continues as first-half organic revenue climbs 16% and core EBIT margin reaches 28% 34
  • 6.5 Jun 20, 2019: Collplant announces corporate name change to Collplant Biotechnologies to better reflect its business 40
  • 6.6 Jun 19, 2019: CelGro accelerates dental implant treatment 40
  • 6.7 May 30, 2019: CollPlant reports first quarter 2019 financial results and provides business update 42
  • 6.8 May 23, 2019: Full availability of Geistlich Fibro-Gide, the alternative soft-tissue graft 44
  • 6.9 May 23, 2019: Credentis and DentaQuest Partner to Bring Innovative Cavity Prevention Products to US Markets 45
  • 6.10 May 22, 2019: CollPlant Launches New HQ and R&D Center in Israel 46
  • 6.11 May 16, 2019: CURODONT REPAIR is the superior treatment for white spots 46
  • 6.12 May 01, 2019: Orthocell submits AUS regulatory application for CelGro 46
  • 6.13 Apr 30, 2019: Promising start to the year with 17% organic growth in first quarter 47
  • 6.14 Apr 11, 2019: CURODONT REPAIR FLUORIDE PLUS - distribution starts in the US 49
  • 6.15 Apr 01, 2019: CollPlant Reports Fourth Quarter and Year End 2018 Financial Results and Provides Business Update 50
  • 6.16 Feb 20, 2019: CURODONT PROTECT - Best Prophylaxis during Orthodontic Treatment 52
  • 6.17 Feb 19, 2019: Straumann posts strong Q4, lifting full-year organic revenue growth to 19% as underlying EBITDA margin reaches 30% 52
  • 6.18 Feb 04, 2019: CollPlant names Jonathan M.N. Rigby as Chairman of the Board 57
  • 6.19 Jan 22, 2019: Straumann Group appoints Alastair Robertson as Head of Global People Management & Development 58

7 Appendix 59

  • 7.1 Methodology 59
  • 7.2 About GlobalData 62
  • 7.3 Contact Us 62
  • 7.4 Disclaimer 62

List of Tables

  • Table 1: Tissue Regenerative Materials - Pipeline Products by Stage of Development 7
  • Table 2: Tissue Regenerative Materials - Pipeline Products by Territory 8
  • Table 3: Tissue Regenerative Materials - Pipeline Products by Regulatory Path 9
  • Table 4: Tissue Regenerative Materials - Pipeline Products by Estimated Approval Date 10
  • Table 5: Tissue Regenerative Materials Companies - Pipeline Products by Stage of Development 11
  • Table 6: Tissue Regenerative Materials - Pipeline Products by Stage of Development 12
  • Table 7: Biora AB Pipeline Products & Ongoing Clinical Trials Overview 13
  • Table 8: Straumann Emdogain FL - Product Status 13
  • Table 9: Straumann Emdogain FL - Product Description 13
  • Table 10: Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview 14
  • Table 11: MatrixMem - Product Status 14
  • Table 12: MatrixMem - Product Description 14
  • Table 13: Socket Repair Kit - Product Status 15
  • Table 14: Socket Repair Kit - Product Description 15
  • Table 15: Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 16
  • Table 16: Xenograft Implant - Dental - Product Status 16
  • Table 17: Xenograft Implant - Dental - Product Description 16
  • Table 18: credentis AG Pipeline Products & Ongoing Clinical Trials Overview 17
  • Table 19: CUROLOX Perio - Product Status 17
  • Table 20: CUROLOX Perio - Product Description 17
  • Table 21: Gene Techno Science Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 18
  • Table 22: GCT-101 - Product Status 18
  • Table 23: GCT-101 - Product Description 18
  • Table 24: Histocell SL Pipeline Products & Ongoing Clinical Trials Overview 19
  • Table 25: Scaffold Regeneration - Oral Masticatory Mucosa Injuries - Product Status 19
  • Table 26: Scaffold Regeneration - Oral Masticatory Mucosa Injuries - Product Description 19
  • Table 27: Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 28: Electrospun Scaffold - Product Status 20
  • Table 29: Electrospun Scaffold - Product Description 20
  • Table 30: Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 31: MaxiGuide - Product Status 21
  • Table 32: MaxiGuide - Product Description 21
  • Table 33: Nobel Biocare Services AG Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 34: Bone Inductive Implant - Product Status 22
  • Table 35: Bone Inductive Implant - Product Description 22
  • Table 36: Novatissue SAS Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 37: OrthoNovaOss - Product Status 23
  • Table 38: OrthoNovaOss - Product Description 23
  • Table 39: Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 40: CelGro - Dental - Product Status 24
  • Table 41: CelGro - Dental - Product Description 24
  • Table 42: Polytechnic University of Catalonia Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 43: Inorganic Dental Cement - Product Status 25
  • Table 44: Inorganic Dental Cement - Product Description 26
  • Table 45: Straumann Holding AG Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 46: Soft Tissue Control Implant - Product Status 27
  • Table 47: Soft Tissue Control Implant - Product Description 27
  • Table 48: SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 49: DentaColl - Product Status 28
  • Table 50: DentaColl - Product Description 28
  • Table 51: SweetBio, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 52: SweetBio GTR (Guided Tissue Regeneration) Membrane - Product Status 29
  • Table 53: SweetBio GTR (Guided Tissue Regeneration) Membrane - Product Description 29
  • Table 54: Tigran Technologies AB Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 55: Tigran Porous Titanium Granules - Alveolar Fillings - Product Status 30
  • Table 56: Tigran Porous Titanium Granules - Alveolar Fillings - Product Description 30
  • Table 57: Glossary 61

List of Figures

  • Figure 1: Tissue Regenerative Materials - Pipeline Products by Stage of Development 7
  • Figure 2: Tissue Regenerative Materials - Pipeline Products by Territory 8
  • Figure 3: Tissue Regenerative Materials - Pipeline Products by Regulatory Path 9
  • Figure 4: Tissue Regenerative Materials - Pipeline Products by Estimated Approval Date 10
Back to Top